在肥胖成年人中,食物成,饮食质量和代谢参数之间是否存在关系? :一个横截面研究示例
Emre Duman1, Alev Keser2, Serkan Asil3
1Department of Nutrition and Dietetics, Ankara University, Institute of Health Sciences, Ankara, Türkiye.
概括
食物成会影响超重和肥胖成年人的饮食质量和代谢健康. 改善饮食的干预措施对于管理肥胖和相关健康问题至关重要.
科学领域:
- 营养科学 营养科学
- 肥胖问题研究研究
- 代谢健康 代谢健康
背景情况:
- 食物成越来越被认为是导致肥胖的重要因素.
- 饮食质量和代谢参数是超重和肥胖人口健康的关键指标.
研究的目的:
- 为了确定超重和肥胖成年人中食物成的患病率.
- 评估食物成,饮食质量和代谢参数之间的关联.
主要方法:
- 一项涉及134名超重和肥胖成年人的横截面研究.
- 使用耶鲁食品成量表 (YFAS) 来评估食物成.
- 采用健康饮食指数-2010 (HEI-2010) 来评估饮食质量.
主要成果:
- 19.4%的参与者表现出食物成.
- 食物成的个体表现出更高的饮食质量差以及升高的AST水平.
- 食物成与增加胆固醇摄入量有关,并与AST,SBP和DBP正相关.
结论:
- 在超重和肥胖成年人中,食物成,饮食质量和代谢参数之间存在潜在的关系.
- 改善饮食质量对于有效的肥胖治疗策略至关重要.
更多相关视频
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
228
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
228
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
162
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
162
Drug Dosing: Obese Patients
204
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
204


